期刊文献+

Chromium Content in the Human Hip Joint Tissues 被引量:1

Chromium Content in the Human Hip Joint Tissues
下载PDF
导出
摘要 Objective Chromium has many important functions in the human body. For the osseous tissue, its role has not been clearly defined. This study was aimed at determining chromium content in hip joint tissues. Methods A total of 91 hip joint samples were taken in this study, including 66 from females and 25 from males. The sample tissues were separated according to their anatomical parts. The chromium content was determined by the AAS method. The statistical analysis was performed with U Mann-Whitney's non-parametric test, P〈0.05. Results The overall chromium content in tissues of the hip joint in the study subjects was as follows: 5.73 μg/g in the articular cartilage, 5.33 μ/g in the cortical bone, 27.86 μ/g in the cancellous bone, 5.95 μg/8 in the fragment of the cancellous bone from the intertrochanteric region, and 2.28 μ/g in the joint capsule. The chromium contents were observed in 2 group patients, it was 7.04 μ/g in people with osteoarthritis and 22.59 μ/g in people with fractures. Conclusion The observed chromium content was highest in the cancellous bone and the lowest in the joint capsule. Chromium content was significantly different between the people with hip joint osteoarthritis and the people with femoral neck fractures. Objective Chromium has many important functions in the human body. For the osseous tissue, its role has not been clearly defined. This study was aimed at determining chromium content in hip joint tissues. Methods A total of 91 hip joint samples were taken in this study, including 66 from females and 25 from males. The sample tissues were separated according to their anatomical parts. The chromium content was determined by the AAS method. The statistical analysis was performed with U Mann-Whitney's non-parametric test, P〈0.05. Results The overall chromium content in tissues of the hip joint in the study subjects was as follows: 5.73 μg/g in the articular cartilage, 5.33 μ/g in the cortical bone, 27.86 μ/g in the cancellous bone, 5.95 μg/8 in the fragment of the cancellous bone from the intertrochanteric region, and 2.28 μ/g in the joint capsule. The chromium contents were observed in 2 group patients, it was 7.04 μ/g in people with osteoarthritis and 22.59 μ/g in people with fractures. Conclusion The observed chromium content was highest in the cancellous bone and the lowest in the joint capsule. Chromium content was significantly different between the people with hip joint osteoarthritis and the people with femoral neck fractures.
出处 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2015年第2期89-96,共8页 生物医学与环境科学(英文版)
基金 financed by the Medical University of Silesia in Katowice(contract No.KNW-1-124/K/4/0)
关键词 CHROMIUM Femur head Hip joint Cortical bone Cancellous bone Chromium Femur head Hip joint Cortical bone Cancellous bone
  • 引文网络
  • 相关文献

参考文献35

  • 1Nordberg GF, Fowler BA, Nordberg M, et al. Handbook on the Toxicology of Metals, Third Edition. London, Amsterdam, Bulingtow, San Diego, Academic Press, 2007; 487-9, 506.
  • 2Kabata-Pendias A, Mukherjee AB. Trace elements from soil to human. Springer Berlin Heidelberg New York, 2007; 182-3.
  • 3Pechova A, Pavlata L. Chromium as an essential nutrient: a review. Vet Med, 2007; 52, 1-18.
  • 4Kirman CR, Aylward LL, Suh M, et al. Physiologically based pharmacokinetic model for humans orally exposed to chromium. Chem-Biollnterac, 2013; 204, 13-27.
  • 5Stoecker BJ. Chromium absorption, safety, and toxicity. J Trace Elem Exp Med, 1999; 12, 163-9.
  • 6Bilezikian JP, Raisz LG, Rodan GA. Principles of Bone Biology.Second Edition Academic Press. Amsterdam: Elsevier Academic Press, 2008; 362-3.
  • 7O'Flaherty E. A phvsiologicallv based model of chromium kinetics in the rat. Toxicol Appl Pharm, 1996; 138,54-64.
  • 8Witmer CM, Harris R. Chromium content of bone after tolerance factor. Toxicologist, 1991; 11,41.
  • 9Brodziak-Dopierala B, Kwapuliriski J, Bogunia M, et al.Metabolizm chromu w glowie kosci udowej w aspekcie nalogu palenia. Przegl Lek, 2006; 63, 1020-2. (In Polish).
  • 10Weber H. Long-term study of the distribution of soluble chromate-51 in the rat after a single intratracheal administration. J Toxicol Environ Health, 1983; 11,749-64.

同被引文献8

引证文献1

二级引证文献1

;
使用帮助 返回顶部